Ultra-Processed Foods' Impact on Obesity
Trial Summary
Will I have to stop taking my current medications?
The trial excludes people who are currently using medications that might affect metabolism or appetite, like metformin or liraglutide. If you're taking such medications, you would not be eligible to participate.
What data supports the effectiveness of the treatment 'Intake of nutritionally diverse ultra-processed foods' for obesity?
Research shows that high consumption of ultra-processed foods is linked to weight gain and a higher risk of obesity. Studies indicate that people who eat more ultra-processed foods tend to consume more calories and gain weight, suggesting that reducing these foods might help prevent or treat obesity.12345
Is the consumption of ultra-processed foods generally safe for humans?
How does the treatment of consuming nutritionally diverse ultra-processed foods differ from other obesity treatments?
This treatment is unique because it involves the intake of ultra-processed foods, which are typically linked to weight gain and obesity, rather than traditional methods that focus on reducing or eliminating such foods. The approach may explore how different types of ultra-processed foods impact obesity, offering insights into their role in weight management.1491011
What is the purpose of this trial?
The changing food environment, with increasingly abundant ultra-processed food (UPF) options, may directly contribute to rising rates of obesity, though it is unknown which ingredients in UPF elevate their reinforcing nature in a way that may lead to overconsumption. The proposed study is the first to systematically examine differences in the rewarding characteristics of and physiological and metabolic responses to UPFs that are high in fat, refined carbohydrates (like sugar), or both. Understanding the biobehavioral underpinnings that enhance the reinforcing potential of ingredients in UPF (e.g., fat vs. refined carbohydrates) can inform novel intervention targets for the treatment of overeating and obesity.
Eligibility Criteria
This trial is for adults aged 18-65 with obesity (BMI ≥ 30 kg/m2) who enjoy certain snack foods and can attend six sessions in Philadelphia. Participants must be able to use a smartphone. Exclusions include non-English speakers, recent significant weight loss or cardiovascular events, certain medication users, those with severe mood disorders or eating disorders, substance abuse issues, diabetes or hypertension diagnosis, and women who are nursing or pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including behavioral tasks to evaluate risk factors for enhanced ultra-processed food reward
Food Consumption Appointments
Participants attend four appointments to consume different types of ultra-processed and minimally processed foods, with assessments of subjective experiences and metabolic responses
Ecological Momentary Assessment (EMA)
Participants complete EMA surveys to assess subjective experiences and real-world food consumption over 5 days following each food consumption appointment
Follow-up
Participants are monitored for safety and effectiveness after the main trial activities, including follow-up assessments of risk factors
Treatment Details
Interventions
- Intake of nutritionally diverse ultra-processed foods
Find a Clinic Near You
Who Is Running the Clinical Trial?
Drexel University
Lead Sponsor